Richard Maziarz

Professor

  • 14796 Citations
  • 64 h-Index
1983 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Richard Maziarz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

The CAR T-cell Consortium, Jan 1 2020, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalReview article

Open Access
  • Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

    Schuster, S. J., Maziarz, R. T., Rusch, E. S., Li, J., Signorovitch, J. E., Romanov, V. V., Locke, F. L. & Maloney, D. G., Apr 14 2020, In : Blood Advances. 4, 7, p. 1432-1439 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

    Maziarz, R. T., Schuster, S. J., Romanov, V. V., Rusch, E. S., Li, J., Signorovitch, J. E., Maloney, D. G. & Locke, F. L., Apr 14 2020, In : Blood Advances. 4, 7, p. 1440-1447 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • Impact of conditioning intensity of allogeneic transplantation for acute myeloid leukemia with genomic evidence of residual disease

    Hourigan, C. S., Dillon, L. W., Gui, G., Logan, B. R., Fei, M., Ghannam, J., Li, Y., Licon, A., Alyea, E. P., Bashey, A., Deeg, H. J., Devine, S. M., Fernandez, H. F., Giralt, S., Hamadani, M., Howard, A., Maziarz, R. T., Porter, D. L., Scott, B. L., Warlick, E. D. & 2 others, Pasquini, M. C. & Horwitz, M. E., Apr 20 2020, In : Journal of Clinical Oncology. 38, 12, p. 1273-1283 11 p.

    Research output: Contribution to journalArticle

  • Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma

    Maziarz, R. T., Waller, E. K., Jaeger, U., Fleury, I., McGuirk, J., Holte, H., Jaglowski, S., Schuster, S. J., Bishop, M. R., Westin, J. R., Mielke, S., Teshima, T., Bachanova, V., Foley, S. R., Borchmann, P., Salles, G. A., Zhang, J., Tiwari, R., Pacaud, L. B., Ma, Q. & 1 others, Tam, C. S., Feb 25 2020, In : Blood Advances. 4, 4, p. 629-637 9 p.

    Research output: Contribution to journalArticle

    Open Access